Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoAt the midpoints, earnings would climb more than 22% as sales rise almost 3%. Pfizer Stock And...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 20 hours agoThe deal is a negative for Covid vaccine rivals Pfizer and Moderna, Leerink Partners analyst...
Kansas Sues Pfizer Over Covid-19 Vaccine’s Safety, Efficacy
Bloomberg Law· 5 days agoThe lawsuit was filed by state Attorney General Kris Kobach in Kansas District Court, Thomas County. Pfizer said its vaccine would prevent the transmission ...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 5 days agoCiting the 69-page lawsuit submitted to the District Court of Thomas County, Fox Business highlights that Pfizer misled the public by claiming its COVID-19 vaccine ...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 5 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 5 days agoNovavax’s filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine manufacturers Moderna (MRNA Quick QuoteMRNA - Free Report) , Novavax and ...
Merck wins U.S. approval for pneumonia vaccine to rival Pfizer’s
Crain's New York Business· 5 days agoCapvaxive has the potential to become the preferred vaccine given studies have shown it protects...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 3 days agoFor them, it has the virtue of being suggestive and unverifiable; with nearly 700 million doses of...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe company says it will have the results of that study soon. Meanwhile, Pfizer began testing its...
Trials to watch: Phase III BCG naïve non-muscle invasive bladder cancer
Clinical Trials Arena via Yahoo Finance· 2 days agoGiven... in patients with NMIBC. This includes AstraZeneca’s Imfinzi (NCT03528694), Pfizer’s...